Pacira | PCRX - Gross Profit On Sales



Pacira reported $125.91M in Gross Profit on Sales for its fiscal quarter ending in June of 2025.


Gross Profit On Sales Change Date
Astellas Pharma JPY 410.96B 28.53B Jun/2025
Bristol-Myers Squibb USD 8.9B 714M Jun/2025
Ironwood Pharmaceuticals USD 3.65M 60.36M Sep/2024
J&J USD 14.6B 816M Mar/2025
Ligand Pharmaceuticals USD 72.86M 32.38M Jun/2025
Novo Nordisk 64.01B 1.19B Jun/2025
Pacira USD 125.91M 8.71M Jun/2025
Perrigo USD 362.9M 29.4M Jun/2025
Pfizer USD 10.88B 248M Jun/2025
Supernus Pharmaceuticals USD 127.81M 6.25M Jun/2025
Teva Pharmaceutical Industries USD 2.1B 188M Jun/2025
Xeris Pharmaceuticals USD 59.64M 9.02M Jun/2025
Zoetis USD 1.78B 180M Jun/2025